Navigation Links
Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
Date:5/16/2008

sults for its Phase 1 program of

R4996/MEM 63908 in the fourth quarter

-- Initiate a Phase 2a trial for MEM 1414 by year-end

-- Initiate a Phase 1 trial for MEM 68626 by year-end.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or Memory Pharmaceuticals' prospects, future financial position, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including the outcome of clinical trials of Memory Pharmaceuticals' drug candidates and whether they demonstrate these candidates' safety and effectiveness; the risks and uncertainties associated with: obtaining additional financing to support Memory Pharmaceuticals' R&D and clinical activities and operations; obtaining regulatory approvals to conduct clinical trials and to commercialize Memory Pharmaceuticals' drug candidates; Memory Pharmaceuticals' ability to enter into and maintain collaborations with third parties for its drug development programs; Memory Pharmaceuticals' dependence on its collaborations and its license relationships; achieving milestones under Memory Pharmaceuticals' collaborations; Memory Pharmaceuticals' d
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Experimental Drug Ketasyn(TM) Improves Memory in Age-Associated Memory Impairment Study
2. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
3. Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease
4. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
5. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
6. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
7. How Big Is Your Brain? Its Size May Protect You from Memory Loss
8. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
9. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire-FirstCall/--NuVasive,Inc.(Nasdaq: NUVA ),a...minimallydisruptivesurgicaltreatmentsforthespine,a...,November30,2009,at5:30p.m.ET/2:30p.m.PT.Theconfer...ementfortheCompany,sproductsandwillincludecomments...sion.Thedial-innumbersare1-877-407-4018fordomestic...
(Date:11/25/2009)...sandJOHANNESBURG,November25/PRNewswire/--,iThembaP...ouncedtoday,thattheyhavesignedacollaborativeagreem...Pyxis,sworldclasscomputationalchemistryandleaddisc...visiontoprovidemedicinaland,syntheticchemistrysupp...clientnetwork.iThembaPharmaceuticalsandPyxisDiscov...
(Date:11/24/2009)...RNewswire/-- ,, WHAT:RomHoubens,aBelgianmanthou...nt,wasactuallyfullyconsciousandawakeduringthattime...naVoxEyeMaxwasfeaturedinthesegmenttoillustratehowp...ockcommunication. ,, WHEN:GoodMorningAmerica-- ...xtech.com ,, WHO:RomHoubenswasanengineering...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Existing Drug May Lead to ALS Treatment 59797 1Existing Drug May Lead to ALS Treatment 59797 2World Osteoporosis Day Call for Immediate Action to Prevent Fractures 14537 1World Osteoporosis Day Call for Immediate Action to Prevent Fractures 14537 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 1Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 2Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 3Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 4Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico 5583 5
...OUNTAIN VIEW, Calif., June 28 MAP,Pharmaceuticals...an in-vitro,study evaluating receptor pharmacology...) for the potential treatment of migraine, compare...among six posters relating,to the MAP0004 program ...e,Society 50th Annual Scientific Meeting in Boston...
...NDIANAPOLIS, June 27 Eli Lilly and Co (NYSE:,LLY)... Committee for,Medicinal Products for Human Use (C...ssued a positive opinion supporting the approval o...reatment of Generalised Anxiety,Disorder (GAD)., ...five clinical studies,-- four double-blind placebo...
Other Medicine Technology:MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting 2MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting 3MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting 4European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 2European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 3European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 4European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 5European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder 6
(Date:11/25/2009)...d to fight rheumatoid arthritis, could help newly ...NESDAY, Nov. 25 (HealthDay News) -- A drug commonl...oid arthritis now also shows some promise in helpi..., The drug, rituximab (Rituxan), helped patient...hough the disease had destroyed some of their panc...
(Date:11/25/2009).../PRNewswire/-- MISSIONSkincare ®isproudtosupp...AspartofGNC,sannualSt.Jude ThanksandGiving campaig... new SUPER-C(TM)LipBalm willbedonatedtoSt.Jude.Ad...,$5or$10donationatcheckoutatoneoftheir5,000+retail...ionforSt.Judeduringtheir2009 ThanksandGiving campa...
(Date:11/25/2009)... problems that can occur in children with autism a...ent plan that includes medication combined with a ... to Yale University researchers and their colleagu...he Journal of the American Academy of Child and A...the National Institute of Mental Health (NIMH) Res...
(Date:11/25/2009)... BioSpace.com, the premier resource for life sc...edition of the BioForest™ Hotbed Campaign th...CO (Vocus) November 25, 2009 -- BioSpace.com, the ...rmation, unveiled the third edition of the BioFore...his regional campaign is a promotional effort high...
(Date:11/25/2009)...estDonationEverMadeinSupportofFeedingAmerica,sSNAP...SNewswire/--FeedingAmerica,thenation,slargesthunge...ionfromtheBankofAmericaCharitableFoundationtosuppo...answiththeSupplementalNutritionAssistanceProgram(S...beusedtohelpFeedingAmericafoodbanksimproveaccessan...
Breaking Medicine News(10 mins):Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3
...Records Success, Sweepstakes to Take Place at This... October 8-10, 2007, ANNAPOLIS, Md., Sept. 26 CB... healthcare BPO services, today announced that,it ... is a great chance for us to thank the entire HIM ...
... 25 The following was,released today by the Offic...he House of Representatives is expected to vote on...p verification standards for,illegal immigrants an... care. Here,s just a sample of some of the more,eg...
...x is at your fingertips, SAN DIEGO, Sept. 25 DEM...onal Input Pod(TM) -- a revolutionary biosensor th...lessly with software applications that run on,Blue...rtable, and empowers individuals to help them take...
... Sept. 25 Elizabeth,Pivonka, Ph.D., R.D., Preside...tion, released the following statement on the stud...rnal of The National Cancer Institute (JNCI),showi...suggest that a diet high in fruits,and vegetables ...
... 25 American Society of,Transplantation (AST) Pas...re the U.S. House of Representatives, Information,... of the Oversight and Government Reform,Committee ...,000 individuals are awaiting a,life-saving donor ...
...dney Disease Education and Awareness - One in Elev...idney Disease, BURLINGAME, Calif., Sept. 25 The ...s Time Walk-a-thon (KAT Walk) in,54 cities in 28 s... and prevention programs. The KAT Walk is a nation...
Other Medicine News:Health News:CBaySystems to Give Away a 2008 Honda Civic at AHIMA 2007 2Health News:'Compromise' SCHIP Deal Substitutes Ideology for Common Sense 2Health News:PIP - A Revolution in Stress Management 2Health News:PIP - A Revolution in Stress Management 3Health News:Produce for Better Health Foundation Releases Statement on Study Saying Fruit & Vegetable Consumption Not Strongly Associated With Colon Cancer Risk 2Health News:American Society of Transplantation's Past President Testifies Before Congress at Forum on Organ Donation 2Health News:Kidney Awareness Time (KAT) Walk Raised Awareness and $400,000 for Kidney Education and Prevention Programs 2
Near Point Card/Newspaper 8 to 48 - BC2203
Hart Card Set 2 Cards - BCHC
...es to many common print sizes, from newspaper head...s provides the examiner a starting point to determ...k on yellow styrene for increased contrast. It fea...otations include Jaeger, M notation, lower case po...
...g card was designed by James Lebensohn, MD and pro...ng words, numbers and OX symbols. Optotypes includ.../50, 20/40, 20/30, 20/25, and 20/20. Notation equi...ric, Jaeger, point size and visual efficiency perc...
Medicine Products: